These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22894453)

  • 1. An approach to identify, from DCE MRI, significant subvolumes of tumors related to outcomes in advanced head-and-neck cancer.
    Wang P; Popovtzer A; Eisbruch A; Cao Y
    Med Phys; 2012 Aug; 39(8):5277-85. PubMed ID: 22894453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological imaging-defined, response-driven subvolumes of a tumor.
    Farjam R; Tsien CI; Feng FY; Gomez-Hassan D; Hayman JA; Lawrence TS; Cao Y
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1383-90. PubMed ID: 23257692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early prediction of outcome in advanced head-and-neck cancer based on tumor blood volume alterations during therapy: a prospective study.
    Cao Y; Popovtzer A; Li D; Chepeha DB; Moyer JS; Prince ME; Worden F; Teknos T; Bradford C; Mukherji SK; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1287-90. PubMed ID: 19028268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive Boost Target Definition in High-Risk Head and Neck Cancer Based on Multi-imaging Risk Biomarkers.
    Teng F; Aryal M; Lee J; Lee C; Shen X; Hawkins PG; Mierzwa M; Eisbruch A; Cao Y
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):969-977. PubMed ID: 29428251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DCE-MRI defined subvolumes of a brain metastatic lesion by principle component analysis and fuzzy-c-means clustering for response assessment of radiation therapy.
    Farjam R; Tsien CI; Lawrence TS; Cao Y
    Med Phys; 2014 Jan; 41(1):011708. PubMed ID: 24387500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Values of MRI and PET Derived Quantitative Parameters for Patterns of Failure in Both p16+ and p16- High Risk Head and Neck Cancer.
    Cao Y; Aryal M; Li P; Lee C; Schipper M; Hawkins PG; Chapman C; Owen D; Dragovic AF; Swiecicki P; Casper K; Worden F; Lawrence TS; Eisbruch A; Mierzwa M
    Front Oncol; 2019; 9():1118. PubMed ID: 31799173
    [No Abstract]   [Full Text] [Related]  

  • 7. Arterial perfusion imaging-defined subvolume of intrahepatic cancer.
    Wang H; Farjam R; Feng M; Hussain H; Ten Haken RK; Lawrence TS; Cao Y
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):167-74. PubMed ID: 24613814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck.
    Chawla S; Kim S; Dougherty L; Wang S; Loevner LA; Quon H; Poptani H
    AJR Am J Roentgenol; 2013 Jan; 200(1):35-43. PubMed ID: 23255739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal Feature Extraction from DCE-MRI to Identify Poorly Perfused Subvolumes of Tumors Related to Outcomes of Radiation Therapy in Head and Neck Cancer.
    You D; Aryal M; Samuels SE; Eisbruch A; Cao Y
    Tomography; 2016 Dec; 2(4):341-352. PubMed ID: 28111634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parametric Response Mapping of Coregistered Positron Emission Tomography and Dynamic Contrast Enhanced Computed Tomography to Identify Radioresistant Subvolumes in Locally Advanced Cervical Cancer.
    Capaldi DPI; Hristov DH; Kidd EA
    Int J Radiat Oncol Biol Phys; 2020 Jul; 107(4):756-765. PubMed ID: 32251757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An exploratory study into the role of dynamic contrast-enhanced (DCE) MRI metrics as predictors of response in head and neck cancers.
    Agrawal S; Awasthi R; Singh A; Haris M; Gupta RK; Rathore RK
    Clin Radiol; 2012 Sep; 67(9):e1-5. PubMed ID: 22583950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early MRI Blood Volume Changes in Constrictor Muscles Correlate With Postradiation Dysphagia.
    Mierzwa ML; Gharzai LA; Li P; Wilkie JR; Hawkins PG; Aryal MP; Lee C; Rosen B; Lyden T; Blakely A; Chapman CH; Thamarus J; Schonewolf C; Shah J; Eisbruch A; Schipper MJ; Cao Y
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):566-573. PubMed ID: 33346093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET-based quantification of statistical properties of hypoxic tumor subvolumes in head and neck cancer.
    Chirla R; Marcu LG
    Phys Med; 2016 Jan; 32(1):23-35. PubMed ID: 26748960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
    Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
    Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of the effects of radiation therapy in esophageal cancer using diffusion and perfusion MRI.
    Wang P; Wang X; Xu L; Yu J; Teng F
    Cancer Sci; 2021 Dec; 112(12):5046-5054. PubMed ID: 34618997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-Time Quantitative Assessment of Accuracy and Precision of Blood Volume Derived from DCE-MRI in Individual Patients During a Clinical Trial.
    Aryal MP; Lee C; Hawkins PG; Chapman C; Eisbruch A; Mierzwa M; Cao Y
    Tomography; 2019 Mar; 5(1):61-67. PubMed ID: 30854443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
    Calais J; Thureau S; Dubray B; Modzelewski R; Thiberville L; Gardin I; Vera P
    J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DCE-MRI for Pre-Treatment Prediction and Post-Treatment Assessment of Treatment Response in Sites of Squamous Cell Carcinoma in the Head and Neck.
    King AD; Chow SK; Yu KH; Mo FK; Yeung DK; Yuan J; Law BK; Bhatia KS; Vlantis AC; Ahuja AT
    PLoS One; 2015; 10(12):e0144770. PubMed ID: 26657972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced MRI evaluates the early response of human head and neck tumor xenografts following anti-EMMPRIN therapy with cisplatin or irradiation.
    Kim H; Hartman YE; Zhai G; Chung TK; Korb ML; Beasley TM; Zhou T; Rosenthal EL
    J Magn Reson Imaging; 2015 Oct; 42(4):936-45. PubMed ID: 25704985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment response assessment of breast masses on dynamic contrast-enhanced magnetic resonance scans using fuzzy c-means clustering and level set segmentation.
    Shi J; Sahiner B; Chan HP; Paramagul C; Hadjiiski LM; Helvie M; Chenevert T
    Med Phys; 2009 Nov; 36(11):5052-63. PubMed ID: 19994516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.